BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 28393248)

  • 1. Epigallocatechin-3-gallate ameliorates insulin resistance in hepatocytes.
    Ma SB; Zhang R; Miao S; Gao B; Lu Y; Hui S; Li L; Shi XP; Wen AD
    Mol Med Rep; 2017 Jun; 15(6):3803-3809. PubMed ID: 28393248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urotensin II-induced insulin resistance is mediated by NADPH oxidase-derived reactive oxygen species in HepG2 cells.
    Li YY; Shi ZM; Yu XY; Feng P; Wang XJ
    World J Gastroenterol; 2016 Jul; 22(25):5769-79. PubMed ID: 27433090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigallocatechin gallate (EGCG) attenuates high glucose-induced insulin signaling blockade in human hepG2 hepatoma cells.
    Lin CL; Lin JK
    Mol Nutr Food Res; 2008 Aug; 52(8):930-9. PubMed ID: 18496818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
    Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
    Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (-)-Epigallocatechin-3-gallate Ameliorates Insulin Resistance and Mitochondrial Dysfunction in HepG2 Cells: Involvement of Bmal1.
    Mi Y; Qi G; Gao Y; Li R; Wang Y; Li X; Huang S; Liu X
    Mol Nutr Food Res; 2017 Dec; 61(12):. PubMed ID: 28869341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Green tea polyphenol epigallocatechin-3-gallate enhance glycogen synthesis and inhibit lipogenesis in hepatocytes.
    Kim JJ; Tan Y; Xiao L; Sun YL; Qu X
    Biomed Res Int; 2013; 2013():920128. PubMed ID: 24066304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cocoa flavonoids attenuate high glucose-induced insulin signalling blockade and modulate glucose uptake and production in human HepG2 cells.
    Cordero-Herrera I; Martín MÁ; Goya L; Ramos S
    Food Chem Toxicol; 2014 Feb; 64():10-9. PubMed ID: 24262486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artichoke (Cynara scolymus L.) water extract alleviates palmitate-induced insulin resistance in HepG2 hepatocytes via the activation of IRS1/PI3K/AKT/FoxO1 and GSK-3β signaling pathway.
    Deng A; Wang Y; Huang K; Xie P; Mo P; Liu F; Chen J; Chen K; Wang Y; Xiao B
    BMC Complement Med Ther; 2023 Dec; 23(1):460. PubMed ID: 38102588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wheat germ peptide improves glucose metabolism and insulin resistance in HepG2 hepatocytes via regulating SOCS3/IRS1/Akt pathway.
    Song H; Huang Q; Zhang Y; Shen X
    Nutr Res; 2023 Dec; 120():135-144. PubMed ID: 38000279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigallocatechin-3-gallate inhibits angiotensin II-induced C-reactive protein generation through interfering with the AT
    Zhao J; Liu J; Pang X; Zhang X; Wang S; Wu D
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Nov; 389(11):1225-1234. PubMed ID: 27492718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigallocatechin gallate protects nerve growth factor differentiated PC12 cells from oxidative-radical-stress-induced apoptosis through its effect on phosphoinositide 3-kinase/Akt and glycogen synthase kinase-3.
    Koh SH; Kim SH; Kwon H; Park Y; Kim KS; Song CW; Kim J; Kim MH; Yu HJ; Henkel JS; Jung HK
    Brain Res Mol Brain Res; 2003 Oct; 118(1-2):72-81. PubMed ID: 14559356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin ameliorates PA-induced insulin resistance through the IRS/AKT/FOXO1 and GSK-3β signaling pathway, and inhibits the inflammatory response in HepG2 cells.
    Zhang H; Ge Z; Tang S; Meng R; Bi Y; Zhu D
    Mol Med Rep; 2017 Aug; 16(2):2295-2301. PubMed ID: 28656239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modified Si-Miao-San extract inhibits inflammatory response and modulates insulin sensitivity in hepatocytes through an IKKβ/IRS-1/Akt-dependent pathway.
    Liu K; Luo T; Zhang Z; Wang T; Kou J; Liu B; Huang F
    J Ethnopharmacol; 2011 Jul; 136(3):473-9. PubMed ID: 21296137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigallocatechin Gallate Inhibits Hepatic Glucose Production in Primary Hepatocytes via Downregulating PKA Signaling Pathways and Transcriptional Factor FoxO1.
    Li X; Chen Y; Shen JZ; Pan Q; Yang W; Yan H; Liu H; Ai W; Liao W; Guo S
    J Agric Food Chem; 2019 Apr; 67(13):3651-3661. PubMed ID: 30875211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistin disrupts glycogen synthesis under high insulin and high glucose levels by down-regulating the hepatic levels of GSK3β.
    Song R; Wang X; Mao Y; Li H; Li Z; Xu W; Wang R; Guo T; Jin L; Zhang X; Zhang Y; Zhou N; Hu R; Jia J; Lei Z; Irwin DM; Niu G; Tan H
    Gene; 2013 Oct; 529(1):50-6. PubMed ID: 23860320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigallocatechin-3-O-gallate (EGCG) protects the insulin sensitivity in rat L6 muscle cells exposed to dexamethasone condition.
    Zhang ZF; Li Q; Liang J; Dai XQ; Ding Y; Wang JB; Li Y
    Phytomedicine; 2010 Jan; 17(1):14-8. PubMed ID: 19819682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligonol promotes glucose uptake by modulating the insulin signaling pathway in insulin-resistant HepG2 cells via inhibiting protein tyrosine phosphatase 1B.
    Bhakta HK; Paudel P; Fujii H; Sato A; Park CH; Yokozawa T; Jung HA; Choi JS
    Arch Pharm Res; 2017 Nov; 40(11):1314-1327. PubMed ID: 29027136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGCG ameliorates high-fat- and high-fructose-induced cognitive defects by regulating the IRS/AKT and ERK/CREB/BDNF signaling pathways in the CNS.
    Mi Y; Qi G; Fan R; Qiao Q; Sun Y; Gao Y; Liu X
    FASEB J; 2017 Nov; 31(11):4998-5011. PubMed ID: 28739640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigallocatechin-3-gallate, a green tea catechin, protects the heart against regional ischemia-reperfusion injuries through activation of RISK survival pathways in rats.
    Kim SJ; Li M; Jeong CW; Bae HB; Kwak SH; Lee SH; Lee HJ; Heo BH; Yook KB; Yoo KY
    Arch Pharm Res; 2014 Aug; 37(8):1079-85. PubMed ID: 24307060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High glucose reduces hepatic glycogenesis by suppression of microRNA‑152.
    Zhao X; Lu Y; Wang F; Dou L; Wang L; Guo J; Li J
    Mol Med Rep; 2014 Oct; 10(4):2073-8. PubMed ID: 25070263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.